Cibenzoline

This classification denotes an anti-arrhythmia agent with the molecular formula C18H18N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) Z7489237QT, chemically known as 1h-imidazole, 2-(2,2-diphenylcyclopropyl)-4,5-dihydro-, (+-)- but more generally known as cibenzoline, which bears US NIH Compound Identifier 2747. European Medicines Agency schedules Cibenzoline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06229MIG. World Health Organization schedules cibenzoline in its Anatomical Therapeutic Chemical (ATC) Classification. CIBENZOLINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule cibenzoline under HS 29332990 and SITC 51573. SMILES: C1CN=C(N1)C2CC2(C3=CC=CC=C3)C4=CC=CC=C4.